Skip to main content
Log in

The clinical utility of 99mTc-HMPAO SPECT in Fahr’s disease

  • Case Report
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Fahr’s disease is a rare neurodegenerative syndrome, characterized by massive symmetrical intracerebral calcifications of the basal ganglia, dentate nuclei of the cerebellum, and the adjacent parenchyma. Computerized tomography (CT) is considerably more sensitive to detect these intracranial calcifications than other imaging modalities. The clinical, CT scan, and 99mTc-D,L-hexamethylpropylene amine oxime (99mTc-HMPAO) brain perfusion single-photon emission computerized tomography (SPECT) findings in a 42-year-old woman with Fahr’s disease are reported, and the clinical utility of 99mTc-HMPAO SPECT findings in Fahr’s disease is discussed in this article. In conclusion, 99mTc-HMPAO brain perfusion SPECT seems to be useful in the clinical approach to Fahr’s disease, and may provide more specific and clinically relevant information when compared with anatomical imaging.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bamberger PH. Beobactungen und bemerkungen uber hirnkrankheiten. Verh Phys Med Ges Wurzburg 1855;6:325–328.

    Google Scholar 

  2. Fahr TH. Idiopathische verkalkung der hirngefasse. Zentralbl Allg Pathol 1930;50:129–133.

    Google Scholar 

  3. Flint J, Goldstein LH. Familial calcification of the basal ganglia: a case report and review of the literature. Psychol Med 1992;22:581–595.

    PubMed  CAS  Google Scholar 

  4. Rasmussen MJ, Pilo L, Nielsen HR. Basal ganglia calcifications demonstrated by CT. Is further investigation necessary when this is found incidentally? Ugeskr Laeger 1991;153:2051–2053.

    CAS  Google Scholar 

  5. Manyam BW, Bhatt MH, Moore WD, Devleschoward AB, Anderson DR, Calne DB. Bilateral striopallidodentate calcinosis: cerebrospinal fluid, imaging, and electrophysiological studies. Ann Neurol 1992;31:379–384.

    Article  PubMed  CAS  Google Scholar 

  6. Ellie E, Julien J, Ferrer X. Familial idiopathic striopallidodentate calcifications. Neurology 1989;39:381–385.

    PubMed  CAS  Google Scholar 

  7. Smits MG, Gabreels FJ, Thijssen HO, ’tLam RL, Notermans SL, ter Haar BG, et al. Progressive idiopathic strio-pallidodentate calcinosis (Fahr’s disease) with autosomal recessive inheritance. Eur Neurol 1983;22:58–64.

    Article  PubMed  CAS  Google Scholar 

  8. Smith FW, Gemmell HG, Sharp PF, Besson JA. Technetium-99m HMPAO imaging in patients with basal ganglia disease. Br J Radiol 1988;61:914.

    PubMed  CAS  Google Scholar 

  9. Uygur GA, Liu Y, Hellman RS, Tikofsky RS, Collier BD. Evaluation of regional cerebral blood flow in massive intracerebral calcifications. J Nucl Med 1995;36:610.

    PubMed  CAS  Google Scholar 

  10. De Cristofaro MT, Sessarego A, Pupi A, Biondi F, Faravelli C. Brain perfusion abnormalities in drug naive, lactate-sensitive panic patients: a SPECT study. Biol Psychiatry 1993;33:505–512.

    Article  PubMed  Google Scholar 

  11. Murphy MJ. Clinical correlations of CT scan-detected calcifications of the basal ganglia. Ann Neurol 1979;6:507–511.

    Article  PubMed  CAS  Google Scholar 

  12. Vles JS, Lodder J, van der Lugt PJ. Clinical significance of basal ganglia calcifications detected by CT (a retrospective study of 33 cases). Clin Neurol Neurosurg 1981;83:253–256.

    Article  PubMed  CAS  Google Scholar 

  13. Harrington MG, Macpherson P, McIntosh WB, Allam BF, Bone I. The significance of the incidental finding of basal ganglia calcification on computed tomography. J Neurol Neurosurg Psychiatry 1981;44:1168–1170.

    Article  PubMed  CAS  Google Scholar 

  14. Stellamor K, Stellamor V. Roentgen diagnosis of Fahr’s disease. Roentgenblatter 1983;36:194–196.

    CAS  Google Scholar 

  15. Kazis AD. Contribution of CT scan to the diagnosis of Fahr’s syndrome. Acta Neurol Scand 1985;36:194–196.

    Google Scholar 

  16. Konig P. Psychopathological alterations in cases of symmetrical basal ganglia sclerosis. Biol Psychiatry 1989;25:459–468.

    Article  PubMed  CAS  Google Scholar 

  17. Kendall B, Cavanagh N. Intracranial calcification in pediatric computed tomography. Neuroradiology 1986;28:324–330.

    Article  PubMed  CAS  Google Scholar 

  18. Taxer F, Haller R, König P. Klinische frühsymptome und CT-Befunde beim Fahr’schen syndrom. Nervenarzt 1986;57:583–588.

    PubMed  CAS  Google Scholar 

  19. Norman D, Diamond C, Boyd D. Relative detectability of intracranial calcifications on computed tomography and skull radiography. J Comput Assist Tomogr 1978;2:61.

    Article  PubMed  CAS  Google Scholar 

  20. Holland BA, Kucharcyzk W, Brant-Zawadzki M, Norman D, Haas DK, Harper PS, et al. MR imaging of calcified intracranial lesions. Radiology 1985;157:353.

    PubMed  CAS  Google Scholar 

  21. Oot RF, New PFJ, Pile-Spellman J, Rosen BR, Shoukimas GM, Davis KR. The detection of intracranial calcifications by MR. AJNR Am Neurolradiol 1986;7:801.

    CAS  Google Scholar 

  22. Henkelman RM, Watts JF, Kucharczyk W. High signal intensity in MR images of calcified brain tissue. Radiology 1991;179:199.

    PubMed  CAS  Google Scholar 

  23. Scotti G, Scialfa G, Tampieri D, Landoni L. MR imaging in Fahr disease. J Comput Assist Tomogr 1985;9:790.

    PubMed  CAS  Google Scholar 

  24. Alexander GE, De Long MR, Strick PL. Parallel organization of functionally segregated circuits linking basal basal ganglia and cortex. Annual Review of Neuroscience 1986;9:357–381.

    Article  PubMed  CAS  Google Scholar 

  25. Ogi S, Fukumitsu N, Tsuchida D, Uchiyama M, Mori Y, Matsui K. Imaging of bilateral striopallidodentate calsinosis. Clin Nucl Med 2002;27:721–724.

    Article  PubMed  Google Scholar 

  26. Shouyama M, Kitabata Y, Kaku T, Shinosaki K. Evaluation of regional cerebral blood flow in Fahr disease with schizophrenia-like psychosis: A case report. AJNR Am J Neuroradiol 2005;26:2527–2529.

    PubMed  Google Scholar 

  27. Hempel A, Henze M, Berghoff C, Garcia N, Ody R, Schroder J. PET findings and neuropsychological deficits in a case of Fahr’s disease. Psychiatry Res 2001;108:133–140.

    Article  PubMed  CAS  Google Scholar 

  28. Benke T, Karner T, Seppi K, Delazer M, Marksteiner J, Donnemiller E. Subacute dementia and imaging correlates in a case of Fahr’s disease. J Nuerol Neurosurg Psychiatry 2007;75:1163–1165.

    Article  Google Scholar 

  29. Le Ber I, Marie RM, Lalevee C, Chabot B, Allouche S, Defer GL. Familial idiopathic striato-pallido-dentate calcifications: clinical and brain imaging study in a family. Rev Neurol (Paris) 2003;159:43–49.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tunc Ones.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ones, T., Dede, F., Gunal, D. et al. The clinical utility of 99mTc-HMPAO SPECT in Fahr’s disease. Ann Nucl Med 22, 425–428 (2008). https://doi.org/10.1007/s12149-007-0121-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-007-0121-0

Keywords

Navigation